Core Alternative Capital’s Medtronic MDT Stock Holding History

Core Alternative Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.45M	Sell	44,037 -5,714	-11%	-$461K	1.03%	41
2026 Q1	$4.31M	Sell	49,751 -3,151	-6%	-$302K	1.27%	33
2025 Q4	$5.08M	Sell	52,902 -3,009	-5%	-$292K	1.4%	24
2025 Q3	$5.33M	Buy	55,911 +14,736	+36%	+$1.35M	1.55%	20
2025 Q2	$3.59M	Buy	41,175 +798	+2%	+$67.7K	0.98%	50
2025 Q1	$3.63M	Sell	40,377 -2,140	-5%	-$191K	0.87%	48
2024 Q4	$3.4M	Buy	42,517 +1,811	+4%	+$157K	0.71%	51
2024 Q3	$3.66M	Sell	40,706 -1,118	-3%	-$94.1K	0.71%	52
2024 Q2	$3.29M	Buy	41,824 +2,831	+7%	+$232K	0.66%	55
2024 Q1	$3.4M	Buy	38,993 +3,348	+9%	+$286K	0.61%	56
2023 Q4	$2.94M	Sell	35,645 -4,230	-11%	-$322K	0.5%	58
2023 Q3	$3.12M	Buy	39,875 +1,874	+5%	+$157K	0.48%	52
2023 Q2	$3.35M	Buy	38,001 +1,527	+4%	+$131K	0.49%	50
2023 Q1	$2.94M	Buy	36,474 +24,667	+209%	+$2.01M	0.39%	50
2022 Q4	$918K	Sell	11,807 -5,221	-31%	-$423K	0.12%	76
2022 Q3	$1.38M	Buy	17,028 +3,900	+30%	+$350K	0.22%	59
2022 Q2	$1.18M	Buy	13,128 +7,024	+115%	+$712K	0.28%	55
2022 Q1	$677K	Buy	6,104 +4,995	+450%	+$528K	0.18%	61
2021 Q4	$115K	Buy	1,109 +922	+493%	+$107K	0.02%	104
2021 Q3	$23K	Buy	+187	New	+$24.2K	﹤0.01%	88

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Core Alternative Capital's MDT Position: Q2 2026 in Review

Core Alternative Capital reduced its Medtronic (MDT) stake by 11% in Q2 2026, selling an estimated $461K and leaving 44,037 shares worth $3.45M. The position accounts for 1.03% of the portfolio, ranked #41.

Core Alternative Capital first reported a position in MDT in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.33M in Q3 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Core Alternative Capital held 44,037 shares of Medtronic worth $3.45M as of Q2 2026.
Core Alternative Capital sold 5,714 Medtronic shares in Q2 2026, an estimated $461K.
Medtronic made up 1.03% of Core Alternative Capital's portfolio in Q2 2026, its #41 holding.
Core Alternative Capital first reported a position in Medtronic in Q3 2021 and has held it in 20 quarters since.
Core Alternative Capital's Medtronic position peaked at $5.33M in Q3 2025.
2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.